EVEN-plus syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:496751OMIM:616854Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

EVEN-plus syndrome is a very rare genetic condition that affects multiple parts of the body. The name stands for Epidermal nevi, Ventricular anomalies, and Eye abnormalities — plus additional features beyond these core findings. It is sometimes referred to as EVEN-plus or epidermal nevus syndrome with additional systemic involvement. The condition is caused by changes (mutations) in the HRAS gene that happen after conception, meaning the mutation is present in only some cells of the body — a situation called somatic mosaicism. People with EVEN-plus syndrome can have a wide range of symptoms. These include skin growths called epidermal nevi (raised, sometimes warty patches of skin), heart defects, eye problems, and brain or nervous system abnormalities. Because the mutation affects different tissues depending on when it occurred during early development, no two people with this condition look exactly alike. There is currently no cure for EVEN-plus syndrome. Treatment focuses on managing each symptom as it appears. This usually means a team of specialists working together — including dermatologists, cardiologists, neurologists, and ophthalmologists. Early diagnosis and regular monitoring are very important to catch and treat complications before they become serious.

Also known as:

Key symptoms:

Raised, thickened, or warty skin patches (epidermal nevi)Heart defects or structural heart problemsEye abnormalities, such as clouding of the lens (cataracts) or problems with the retinaBrain abnormalities visible on imagingSeizures or epilepsyIntellectual disability or learning difficultiesOvergrowth of certain body parts or tissuesSkeletal abnormalities such as bone deformitiesKidney or urinary tract problemsHearing lossAbnormal blood vessel growth

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for EVEN-plus syndrome.

View clinical trials →

No actively recruiting trials found for EVEN-plus syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the EVEN-plus syndrome community →

No specialists are currently listed for EVEN-plus syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to EVEN-plus syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open EVEN-plus syndromeForum →

No community posts yet. Be the first to share your experience with EVEN-plus syndrome.

Start the conversation →

Latest news about EVEN-plus syndrome

No recent news articles for EVEN-plus syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which organs are affected in my child's case, and how severe is the involvement?,Should we do genetic testing on skin tissue rather than blood, and what will the results tell us?,What specialists should be part of our care team, and how often should we see each one?,Are there any clinical trials or research studies we should know about?,What signs or symptoms should prompt us to seek emergency care immediately?,How might this condition change as my child grows older?,What educational or developmental support services should we pursue right away?

Common questions about EVEN-plus syndrome

What is EVEN-plus syndrome?

EVEN-plus syndrome is a very rare genetic condition that affects multiple parts of the body. The name stands for Epidermal nevi, Ventricular anomalies, and Eye abnormalities — plus additional features beyond these core findings. It is sometimes referred to as EVEN-plus or epidermal nevus syndrome with additional systemic involvement. The condition is caused by changes (mutations) in the HRAS gene that happen after conception, meaning the mutation is present in only some cells of the body — a situation called somatic mosaicism. People with EVEN-plus syndrome can have a wide range of symptoms.

How is EVEN-plus syndrome inherited?

EVEN-plus syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does EVEN-plus syndrome typically begin?

Typical onset of EVEN-plus syndrome is neonatal. Age of onset can vary across affected individuals.